Skip to content

Glenmark Pharma Q3 PAT rises 21.3% to Rs 290.8 crore

Consolidated revenue was at Rs 3,463.9 crore, as against Rs 3,173.4 crore, up 9.2 per cent, Glenmark Pharmaceuticals said.

Read More

​ Consolidated revenue was at Rs 3,463.9 crore, as against Rs 3,173.4 crore, up 9.2 per cent, Glenmark Pharmaceuticals said. Consolidated revenue was at Rs 3,463.9 crore, as against Rs 3,173.4 crore, up 9.2 per cent, Glenmark Pharmaceuticals said.  Moneycontrol Latest News Read More  

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish